INVENTIVA: Results of the Votes of the Combined Shareholders' General Meeting of November 27, 2025

November 28, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development ...